目的：研究DT390-IL2重组质粒对实验性变态反应性脑脊髓炎（EAE）的治疗效果。
Objective:To study the curative effect of EAE with DT390-IL2 recombinant plasmid.
那些对治疗效果不满意的患者还说：他们的保健提供者并不了解他们的变态反应治疗的需要，而且并不认为他们的变态反应症状非常严重。
Those who were dissatisfied also said their health care provider does not understand their allergy treatment needs and does not take their allergy symptoms seriously.
对558名2 ~ 11岁常年性变态反应性鼻炎患儿进行另一项研究，以安慰剂组为对照，比较氟替卡松安特酰胺鼻腔喷雾110mcg和55mcg长期治疗的效果。
Another study compared the effects of long-term treatment with FFNS at 110 MCG and 55 MCG, versus placebo, of year-round allergies in 558 children ages 2 through 11.
应用推荐